Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

AMLODIPINE vs AMLODIPINE\ATORVASTATIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

AMLODIPINE vs AMLODIPINE\ATORVASTATIN: Safety Overview

Metric AMLODIPINE AMLODIPINE\ATORVASTATIN
Total FAERS Reports 64,924 636
Deaths Reported 10,161 44
Death Rate 15.7% 6.9%
Hospitalizations 26,787 133
Average Patient Age 62.8 yrs 69.5 yrs
% Female Patients 57.0% 59.0%
FDA Approval Date Apr 12, 2011 N/A
Manufacturer Teva Pharmaceuticals USA, Inc. N/A
Route ORAL N/A
Marketing Status Prescription N/A